Report for: Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)

Title	Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)
Published in	Trials, September 2020
DOI	10.1186/s13063-020-04581-y
Pubmed ID	32917288
Authors	Kathrin Wode, Johanna Hök Nordberg, Gunver S. Kienle, Nils O. Elander, Britt-Marie Bernhardson, Berit Sunde, Lena Sharp, Roger Henriksson, Per Fransson

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Unknown	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	44	100%

Readers by professional status	Count	As %
Student > Bachelor	3	7%
Student > Master	3	7%
Student > Doctoral Student	3	7%
Unspecified	2	5%
Researcher	2	5%
Other	5	11%
Unknown	26	59%

Readers by discipline	Count	As %
Nursing and Health Professions	7	16%
Unspecified	2	5%
Medicine and Dentistry	2	5%
Engineering	2	5%
Biochemistry, Genetics and Molecular Biology	1	2%
Other	2	5%
Unknown	28	64%

Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled…